Zacks Research Has Bullish Estimate for Integer Q1 Earnings

Integer Holdings Co. (NYSE:ITGR - Free Report) - Zacks Research increased their Q1 2026 earnings estimates for shares of Integer in a research report issued on Thursday, May 15th. Zacks Research analyst R. Department now expects that the medical equipment provider will earn $1.61 per share for the quarter, up from their prior forecast of $1.59. The consensus estimate for Integer's current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer's Q2 2026 earnings at $1.62 EPS.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. During the same period in the previous year, the business earned $1.14 EPS. The business's quarterly revenue was up 7.3% compared to the same quarter last year.

A number of other equities research analysts have also recently commented on ITGR. KeyCorp lowered their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Raymond James upped their price target on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Citigroup upgraded shares of Integer from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $133.00 to $140.00 in a research note on Thursday. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Finally, Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday. Two analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $145.00.

Integer Stock Down 0.7%

Shares of NYSE ITGR traded down $0.83 during trading on Monday, hitting $118.05. The stock had a trading volume of 524,054 shares, compared to its average volume of 371,572. The company has a market capitalization of $4.12 billion, a PE ratio of 35.13, a PEG ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a fifty day moving average of $118.43 and a two-hundred day moving average of $129.34. Integer has a 12 month low of $104.93 and a 12 month high of $146.36.

Institutional Trading of Integer

Institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in shares of Integer in the fourth quarter worth about $38,073,000. Vaughan Nelson Investment Management L.P. bought a new position in Integer in the first quarter worth approximately $33,337,000. Capital Research Global Investors lifted its holdings in Integer by 16.0% during the fourth quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock worth $186,960,000 after buying an additional 194,895 shares during the period. Artisan Partners Limited Partnership purchased a new stake in Integer during the fourth quarter worth $22,775,000. Finally, Nuveen LLC bought a new stake in Integer during the 1st quarter valued at $17,634,000. Institutional investors own 99.29% of the company's stock.

Insider Buying and Selling

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at $5,788,990. This trade represents a 87.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.16% of the stock is currently owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.